Qsemble Capital Management’s Amgen AMGN Stock Holding History

Qsemble Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,165	Closed	-$11.3M	–	381
2026 Q1	$11.3M	Buy	+32,165	New	+$11.5M	0.86%	19
2025 Q3	–	Sell	-14,827	Closed	-$4.14M	–	454
2025 Q2	$4.14M	Sell	14,827 -9,422	-39%	-$2.67M	0.4%	83
2025 Q1	$7.55M	Buy	24,249 +5,100	+27%	+$1.51M	0.8%	23
2024 Q4	$4.99M	Buy	19,149 +18,436	+2,586%	+$5.47M	0.66%	34
2024 Q3	$230K	Buy	+713	New	+$233K	0.04%	338
2024 Q2	–	Sell	-6,019	Closed	-$1.71M	–	419
2024 Q1	$1.71M	Buy	6,019 +978	+19%	+$286K	0.37%	93
2023 Q4	$1.45M	Buy	+5,041	New	+$1.37M	0.36%	88
2023 Q3	–	Sell	-4,600	Closed	-$1.02M	–	320
2023 Q2	$1.02M	Buy	4,600 +2,250	+96%	+$522K	0.72%	51
2023 Q1	$568K	Sell	2,350 -3,000	-56%	-$736K	0.38%	100
2022 Q4	$1.41M	Buy	+5,350	New	+$1.43M	0.98%	28

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Qsemble Capital Management's AMGN Position: Q2 2026 in Review

Qsemble Capital Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 32,165 shares — an estimated $11.3M sold.

Qsemble Capital Management first reported a position in AMGN in Q4 2022 and held it in 10 quarters. The position peaked at $11.3M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Qsemble Capital Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
Qsemble Capital Management sold 32,165 Amgen shares in Q2 2026, an estimated $11.3M.
Qsemble Capital Management first reported a position in Amgen in Q4 2022 and held it in 10 quarters.
Qsemble Capital Management's Amgen position peaked at $11.3M in Q1 2026.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.